"10.1371_journal.pone.0005647","plos one","2009-05-21T00:00:00Z","Marit G A van Vonderen; Michiel A van Agtmael; Elly A M Hassink; Ana Milinkovic; Kees Brinkman; Suzanne E Geerlings; Matti Ristola; Arne van Eeden; Sven A Danner; Peter Reiss; for the MEDICLAS study group","Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands; International Antiviral Therapy Evaluation Center, Amsterdam, The Netherlands; Hospital Clinic, Barcelona, Spain; Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands; Academic Medical Center, Department of Infectious Diseases, Tropical Medicine and AIDS and Center for Infection and Immunity Amsterdam (CINIMA), Amsterdam, The Netherlands; Helsinki University Central Hospital, Helsinki, Finland; Medisch Centrum Jan van Goyen, Amsterdam, the Netherlands","Conceived and designed the experiments: MGAvV MAvA SEG SAD PR. Performed the experiments: MGAvV AM. Analyzed the data: MGAvV MAvA EAMH SAD PR. Wrote the paper: MGAvV MAvA EAMH AM KB SEG MR AvE SAD PR. Analysis and interpretation of the data: EAMH. Acquisition and interpretation of the data: AM KB SEG MR AvE.","Marit van Vonderen reports having received reimbursement of travel costs for international conferences from Abbott, Boehringer Ingelheim and UCB Pharma. Peter Reiss reports having received research grants and/or honoraria for consultancy/advisory boards or speaking engagements from Gilead Sciences, Boehringer Ingelheim, Hoffman LaRoche, GlaxoSmithKline, Merck & Co, Bristol Myers Squibb, Tibotec and Theratechnologies. Sven Danner reports having received honoraria for the advisory board from GlaxoSmithKline. Michiel van Agtmael declares having received honoraria for giving lectures and participating in advisory boards/expert panels of Glaxo Smith Kline, Bristol Myers Squib, Boehringer Ingelheim and Merck and having received a research grant from Abbott. Kees Brinkman declares having received honoraria for giving lectures and participating in advisory boards/expert panels of Glaxo Smith Kline, MSD, Gilead, Roche, Pfizer and BMS. Matti Ristola reports having received research grants and/or honoraria for consultancy/advisory boards or speaking engagements from Abbott, Boehringer Ingelheim, Hoffman LaRoche, GlaxoSmithKline, Merck & Co, Bristol Myers Squibb, Tibotec, Swedish Orphan, Pfizer and Schering-Plough. Suzanne Geerlings reports having received honoraria for the advisory board from MSD. Elly Hassink, Ana Milinkovic and Arne van Eeden report no conflict of interest.","2009","05","Marit G A van Vonderen","MGAVV",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
